文献速递细菌感染、耐药与抗菌药物医院感染防控

澳大利亚全国儿童抗菌药物耐药监测进展:金黄色葡萄球菌、肠球菌及革兰阴性菌菌血症

Progress towards a coordinated, national paediatric antimicrobial resistance surveillance programme: Staphylococcus aureus, enterococcal and Gram-negative bacteraemia in Australia.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该研究基于2013-16年澳大利亚34家医院的前瞻性耐药监测数据,比较≤18岁儿童与>18岁成人金黄色葡萄球菌、肠球菌及革兰阴性菌菌血症。儿童耐药率更低、临床与分子表型不同、死亡率更低,但革兰阴性菌耐药负担在儿童中不成比例,ESBL菌血症死亡 odds 较非ESBL更高。

要点

  • 儿童与成人菌血症耐药谱、表型和预后存在显著差异,儿童并非「小成人」。
  • 儿童革兰阴性菌耐药负担不成比例,ESBL菌血症死亡风险相对更高。
  • 将抗菌药物耐药监测纳入常规实验室实践对指南、管理与新药研发优先级至关重要。

核心结论

  • 儿童在耐药时代并非「小成人」,按年龄组分析有助于发现抗菌药物敏感性、临床表型和遗传毒力因子的差异。
  • 将抗菌药物耐药监测纳入常规实验室实践对指导抗菌药物指南、抗菌药物管理及新药研发优先级至关重要。

研究设计与样本

  • 基于前瞻性协调抗菌药物耐药监测项目,纳入2013-16年澳大利亚34家医院血培养阳性的金黄色葡萄球菌、肠球菌属或革兰阴性菌菌血症患者。
  • 评估对象为≤18岁儿童与>18岁成人,对关键脓毒症病原体采用一致方法学并进行儿童与成人比较分析。

主要发现

  • 儿童与成人在全国抗菌药物耐药数据集中存在鲜明对比,包括儿童耐药率更低、临床与分子表型不同、死亡率更低。
  • 革兰阴性菌耐药负担在儿童中不成比例,儿童ESBL菌血症较非ESBL菌血症的死亡 odds 高于成人相应比较。

临床怎么用

  • 临床应认识到儿童菌血症的耐药谱与成人不同,按年龄组解读药敏与预后。
  • 儿童革兰阴性菌菌血症尤其ESBL感染者需关注较高死亡风险。
  • 抗菌药物耐药监测应嵌入常规实验室流程以支持指南与管理决策。

局限性

  • 研究仅纳入澳大利亚34家医院2013-16年数据,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is increasing knowledge of antimicrobial usage in children yet limited availability of nationally representative paediatric-specific data on antimicrobial resistance. OBJECTIVES: Paediatric data from this national surveillance programme are presented to explore differences between childhood and adult bloodstream infections and antimicrobial resistance surveillance. METHODS: Using information collected from a prospective coordinated antimicrobial resistance surveillance programme, children ≤18 years and adults >18 years with a positive blood culture for Staphylococcus aureus, Enterococcus spp. or Gram-negative spp. presenting to one of 34 Australian hospitals during 2013-16 were evaluated. Consistent methodologies for key sepsis pathogens were employed and a comparative analysis between children and adults was conducted. RESULTS: There are stark contrasts between children and adults in this national antimicrobial resistance (AMR) data set. Notable differences include lower rates of AMR, different clinical and molecular phenotypes and lower mortality amongst children. The burden of Gram-negative resistance is disproportionately experienced in children, with higher odds of death with an ESBL versus non-ESBL bacteraemia in comparison with adults. CONCLUSIONS: These data support that children are not just 'little adults' in the AMR era, and analyses by age group are important to detect differences in antibiotic susceptibility, clinical phenotype and genetic virulence factors. Antimicrobial surveillance incorporated into routine laboratory practice is vital to inform an array of wider applications including antimicrobial guidelines, stewardship and direction for prioritization of novel antimicrobial development.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Campbell AJ, Daley DA, Bell JM, et al. Progress towards a coordinated, national paediatric antimicrobial resistance surveillance programme: Staphylococcus aureus, enterococcal and Gram-negative bacteraemia in Australia. J Antimicrob Chemother. 2020. PMID: 32155261. doi:10.1093/jac/dkaa065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。